Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 2, 2016BloodOpen Access

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

FNFerran NadeuCentro de Investigación Biomédica en Red de CáncerJDJulio DelgadoBarcelona Supercomputing CenterCRCristina RoyoUniversitat Internacional de Catalunya

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nadeu et al. (2016) studied this question.

synapsesocial.com/papers/6a11ca6eed9c06332dfd3796https://doi.org/10.1182/blood-2015-07-659144
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Sequence Alignment/Map format and SAMtools2009 · 69,282 citations
  2. 2Mutation Status of the Residual ATM Allele Is an Important Determinant of the Cellular Response to Chemotherapy and Survival in Patients With Chronic Lymphocytic Leukemia Containing an 11q Deletion2007 · 247 citations
  3. 3Comparison of Normalization Methods for Construction of Large, Multiplex Amplicon Pools for Next-Generation Sequencing2010 · 90 citations
  4. 4ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data2010 · 15,977 citations
  5. 5Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia2008 · 695 citations